Amgen hires comedian Jay Leno to front cholesterol awareness by Beth Snyder Bulik Monday, March 18, 2019 Comedian and TV host Jay Leno teamed with Amgen, maker of the PCSK9 drug Repatha, for a 'Cholesterol 911' awareness push.
Pharma ad police issues first warning of 2019 by Beth Snyder Bulik Friday, March 15, 2019 The first FDA drug marketing warning letter of the year goes to ... a drug that’s not yet approved.
Fox News faces more pharma advertiser defections by Beth Snyder Bulik Thursday, March 14, 2019 After some drug advertisers dropped out last week, Fox host Jeanine Pirro's show didn't air Saturday and isn't scheduled this week.
Sandoz SXSW hackathon names 3 winners by Beth Snyder Bulik Wednesday, March 13, 2019 At South by Southwest, Novartis' Sandoz hackathon judges were so impressed by the finalists that they named three winners instead of the planned one.
BioMarin expands seizure testing program by Beth Snyder Bulik Wednesday, March 13, 2019 BioMarin and Invitae are expanding their free genetic testing program for children with seizures with new partners and a wider patient age range.
Tucker Carlson's insults put pharma advertisers in hot seat by Beth Snyder Bulik Tuesday, March 12, 2019 Fox TV host Tucker Carlson is courting controversy again, and his show's advertisers—including some top drugmakers—are taking heat.
PhRMA ads target proposals to revamp Medicare drug coverage by Beth Snyder Bulik Monday, March 11, 2019 A new ad campaign from the pharma industry's trade group weighs in on proposed changes to Medicare.
Sun debuts first TV campaign for psoriasis entry Ilumya by Beth Snyder Bulik Monday, March 11, 2019 Sun Pharma debuts its first TV ad for psoriasis treatment Ilumya as national TV campaigns become table stakes in the crowded psoriasis category.
GSK's Tesaro taps Scott Foley on ovarian cancer maintenance push by Beth Snyder Bulik Wednesday, March 6, 2019 GSK's Tesaro has partnered with actor Scott Foley for the newest PSA in its initiative to raise awareness of ovarian cancer maintenance treatment.
AbbVie returns to top pharma's February TV spenders by Beth Snyder Bulik Wednesday, March 6, 2019 AbbVie’s Humira was the No. 1 pharma TV ad spender again in February, swapping places with Pfizer’s anti-inflammatory drug Xeljanz.
